- The results of a Friday announcement from Pfizer (NYSE:PFE) hit the markets this morning, in which Pfizer terminated licenses to three products developed in part … Continue Reading
Read now- Auxilium Pharmaceuticals (NASDAQ:AUXL) announced top-line data from a Phase IIIb trial evaluating treatment with Xiaflex for multiple Dupuytren’s Contracture cords at one time. The company … Continue Reading
Read now- Partners Salix Pharmaceuticals (NASDAQ:SLXP) and Progenics Pharmaceuticals (NASDAQ:PGNX) are trading sharply lower today as the FDA did not grant approval of their application for Relistor … Continue Reading
Read nowResearch - Short interest in ResMed Inc. (NYSE:RMD) is at its highest point this year, signaling that investors are growing increasingly bearish on the company’s valuation and … Continue Reading
Read now- Shares of ViroPharma Inc. (NASDAQ:VPHM) are up 5% today on news that the company’s Cinryze C1 esterase inhibitor is featured in July’s online edition of … Continue Reading
Read now- Merck (NYSE:MRK) beat analyst earnings estimates this morning, posting $1.05 per share compared to average expectations of $1.01. The company increased its revenue from last … Continue Reading
Read nowLong Ideas - Sucampo Pharmaceuticals (NASDAQ: SCMP) and marketing partner Takeda, announced the filing of a supplemental NDA (sNDA) for Amitiza for the treatment of opioid induced constipation (OIC) in … Continue Reading
Read now